PELL Bio-Med Technology Co (TPE:6949) Operating Margin %: -2,869.75% (As of Dec. 2025)


TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$862.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co Operating Margin %?

PELL Bio-Med Technology Co TPE:6949 -1.93% 13 Operating Margin % is -2,869.75% as of Dec. 2025. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review. Among 944 Biotechnology companies, PELL Bio-Med Technology Co ranks worse than 82.52% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. PELL Bio-Med Technology Co's Operating Income for the three months ended in Dec. 2025 was NT$-174.17 Mil. PELL Bio-Med Technology Co's Revenue for the three months ended in Dec. 2025 was NT$6.07 Mil. Therefore, PELL Bio-Med Technology Co's Operating Margin % for the quarter that ended in Dec. 2025 was -2,869.75%.

The historical rank and industry rank for PELL Bio-Med Technology Co's Operating Margin % or its related term are showing as below:

TPE:6949' s Operating Margin % Range Over the Past 10 Years
Min: -2280.52   Med: -1487.24   Max: -1375.79
Current: -1487.24


TPE:6949's Operating Margin % is ranked worse than
82.52% of 944 companies
in the Biotechnology industry
Industry Median: -86.83 vs TPE:6949: -1487.24

PELL Bio-Med Technology Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

PELL Bio-Med Technology Co's Operating Income for the three months ended in Dec. 2025 was NT$-174.17 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-467.35 Mil.


PELL Bio-Med Technology Co  (TPE:6949) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


PELL Bio-Med Technology Co Operating Margin % Related Terms


PELL Bio-Med Technology Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for PELL Bio-Med Technology Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co Operating Margin % Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
-1,402.03 -1,375.79 -2,280.52 -2,106.35 -1,487.24

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,306.36 -710.27 -1,414.26 -1,662.02 -2,869.75

TPE:6949 vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, PELL Bio-Med Technology Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PELL Bio-Med Technology Co Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's Operating Margin % falls into.


TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

PELL Bio-Med Technology Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-467.35 / 31.424
=-1,487.24 %

PELL Bio-Med Technology Co's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-174.165 / 6.069
=-2,869.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -2,869.75% mean?
PELL Bio-Med Technology Co (TPE:6949) has a Operating Margin % of -2,869.75% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on PELL Bio-Med Technology Co and its competitors. According to the industry distribution chart, PELL Bio-Med Technology Co ranks #779 out of 944 companies in the Biotechnology industry, placing it in the top 82.5%.
Is PELL Bio-Med Technology Co's Operating Margin % too high?
PELL Bio-Med Technology Co's current Operating Margin % is -2,869.75%. Based on the distribution chart, PELL Bio-Med Technology Co ranks #779 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PELL Bio-Med Technology Co ranks #779 out of 944 companies for Operating Margin %. This places PELL Bio-Med Technology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on PELL Bio-Med Technology Co and its competitors. PELL Bio-Med Technology Co's current Operating Margin % is -2,869.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current Operating Margin % of -2,869.75%. The current Operating Margin % is -2,869.75%. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current Operating Margin % is -2,869.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$862.00
Price